Skip to main content

Table 2 Secondary endpoints: Intraoperative hemodynamic parameters at T3–5 and total amount of transfusion at the end of surgery

From: Impact of brief prewarming on anesthesia-related core-temperature drop, hemodynamics, microperfusion and postoperative ventilation in cytoreductive surgery of ovarian cancer: a randomized trial

 

prewarm [mean; (SD)]

standard [mean; (SD)]

MAP (mmHg)

 T3

80

(±12)

77

(±18)

 T4

77

(±10)

74

(±17)

 T5

78

(±9)

75

(±17)

HR (bpm)

 T3

62

(±13)

60

(±15)

 T4

68

(±12)

65

(±15)

 T5

72

(±16)

71

(±19)

SVV (%)

 T3

9

(±3)

8

(±3)

 T4

9

(±3)

9

(±3)

 T5

9

(±3)

9

(±3)

SV (ml)

 T3

69

(±12)

67

(±16)

 T4

74

(±18)

73

(±21)

 T5

81

(±21)

77

(±24)

PPV (%)

 T3

7

(±3)

7

(±3)

 T4

9

(±3)

8

(±3)

 T5

9

(±5)

9

(±5)

Norepinephrine (μg/kg/min)

 T3

0.03

(± 0.02)

0.03

(±0.02)

 T4

0.06

(±0.04)

0.06

(±0.04)

 T5

0.07

(±0.05)

0.07

(±0.04)

Transfusion (ml)

 FFP at T7

3500

(±2300)

3700

(±2200)

 RBC at T7

1000

(±600)

1000

(±900)

  1. *p < 0.05; MAP mean arterial pressure, HR heart rate, SVV Stroke volume variation, SV Stroke volume, PPV pulse pressure variation, FFP fresh frozen plasma, RBC red blood cells concentrates